(Q62033160)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

D G MacManus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

D H Miller

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

L Kappos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

R Gold

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

E Havrdova

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

V Limmroth

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

C H Polman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

K Schmierer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

T A Yousry

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

M Eraksoy

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

E Meluzinova

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

M Dufek

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

M Yang

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

G N O'Neill

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

K Dawson

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

21 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

258

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

449-456

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963434%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-010-5777-z

15 February 2020

exact match

0 references

cites work

The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MS

1 reference

12 December 2020

Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes".

1 reference

12 December 2020

An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements

1 reference

12 December 2020

Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes

1 reference

12 December 2020

1 reference

12 December 2020

Detoxication enzyme inducers modify cytokine production in rat mixed glial cells

1 reference

12 December 2020

Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis

1 reference

12 December 2020

Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR.

1 reference

12 December 2020

Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2

1 reference

12 December 2020

Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration

1 reference

12 December 2020

Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury

1 reference

12 December 2020

Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis

1 reference

12 December 2020

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

1 reference

12 December 2020

Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis.

1 reference

12 December 2020

Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology.

1 reference

12 December 2020

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

12 December 2020

Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 (Nrf2) in spinal cord astrocytes: consequences for motor neuron survival.

1 reference

12 December 2020

Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells

1 reference

12 December 2020

Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.

1 reference

12 December 2020

Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain

1 reference

12 December 2020

Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression

1 reference

12 December 2020

New acute and chronic black holes in patients with multiple sclerosis randomised to interferon beta-1b or glatiramer acetate

1 reference

12 December 2020

Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers

1 reference

12 December 2020

Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy.

1 reference

12 December 2020

Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.

1 reference

12 December 2020